Abstract
Objective: To evaluate treatment-related toxicities in young head and neck cancer (HNC) patients. Study Design: This was a retrospective observational study designed to access oral toxicities of cancer treatment in young ( 58 years of age, group II) HNC patients with similar tumor stage and treatment protocols. Oral mucositis (OM), xerostomia, dysphagia, dysgeusia, trismus, and radiodermatitis were assessed during days 7, 21, and 35 of head and neck radiotherapy (RT). Results: Patients from both groups showed high incidence and severity of oral toxicities by the end of the RT with OM (81.9% and 63.6%, respectively) and xerostomia (72.6% and 77.2%, respectively) as the most prevalent toxicities for this period of assessment. No differences regarding xerostomia, dysphagia, dysgeusia, and radiodermatitis incidence or severity could be observed between groups. However, higher incidences and severity of OM and trismus were observed throughout the treatment in young patients compared with older patients (P
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
